Insulet
- PODD
- NASDAQ
- Consumer Products
- Latest 29.74
- Currency US$
- Change
- Percent Change
- Volume 438,034
- Tue May 21, 2013 4:00 PM EDT NASDAQ data delayed 15 minutes.
The Globe and Mail
- Open 29.72
- Previous Close 29.74
- High 30.07
- Low 29.645
- Bidx1 27.00
- Askx0 --
- 52-week High 05/20 30.00
- 52-week Low 06/04 17.34
- Beta 0.754
- Market Cap 1,579.19M
- EPS -0.97
- P/E --
- Forward P/E 247.833
- PEG --
- Annual Dividend --
- Yield --
News
Financials & Calendars
- Sales $220,970,000
- Earnings $-47,740,000
- Return on Equity n/a
- Cash Flow --
- Cash $148,060,000
- Current Ratio 4.53
12 months ended Mar 31, 2013.
Trailing 12 month results shown above.
All data is in U.S. dollars.
- Assets $280,890,000
- Liabilities $151,350,000
- Liabilities-to-Equity Ratio 1.17
Price Ratios
- Price to Sales 7.15
- Price to Book 12.19
- Price to Cash Flow n/a
Event Calendar
| Event | Last | Next | ||
|---|---|---|---|---|
| Earnings | May 6 | $-0.21 | Aug 7 | $-0.18 |
| Surprises | May 6 | -4.76% | n/a | n/a |
| Dividends | n/a | n/a | n/a | n/a |
| Splits | n/a | -- | n/a | n/a |
12 months ended May 21, 2013.
A look at major corporate events and financial announcements that are coming up.
Company Information
About the Company
INSULET CORPORATION is an innovative medical device company dedicated to improving the lives of people with diabetes. The Company's OmniPod Insulin Management System is a revolutionary, discreet and easy-to-use insulin infusion system that features two easy-to-use components with no tubing and fully-automated cannula insertion. Through the OmniPod System, Insulet seeks to expand the use of continuous subcutaneous insulin infusion (CSII) therapy among people with insulin-dependent diabetes.
Officers
- Duane DeSisto President; C.E.O. & Dir
- Brian Roberts Chief Financial Officer
- Company Type: n/a
- Company Status: n/a
- Full-time Employees: n/a
-
Incorporation:
United States,
n/a -
Top 1000 Ranking:
Profit: n/a
Revenue: n/a
Assets: n/a
Head Office
9 OAK PARK DRIVEBEDFORD, MA
01730
Phone: (781)-457-5000
Fax: (781)-4575011
Ideas & Discussion
Live Discussion of PODD on StockTwits